Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHA/688221 stock hub

SHA/688221 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHA/688221is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

8.4B

Shanghai Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHA/688221

In the news

Latest news · SHA/688221

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E936.9

P25 17.1P50 24.2P75 37.8

Trailing P/E2,435.3

P25 23.5P50 41.3P75 83.2

ROE0.3

P25 -0.9P50 4.1P75 8.8

ROIC1.2

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHA/688221 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

184

Groups with data

Currency

CNY

Showing 184 of 184 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	524
Employees Change	222%
Employees Change Percent	73.51
Enterprise value	CNY 8.2B
Exchange	Shanghai Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Last refreshed	2026-05-10
Market cap	CNY 8.4B
Price	CNY 22.51
Price currency	CNY
Rev Per Employee	1,298,643.07x
Sector	Healthcare
Sic	2836
Symbol	sha/688221
Website	https://www.frontierbiotech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.04%
EV Earnings	2,360.79x
EV/EBIT	286.03x
EV/EBITDA	106.13x
EV/FCF	323.4x
EV/Sales	20.84x
FCF yield	0.3%
Forward P/E	936.86x
P/B ratio	7.61x
P/E ratio	2,435.35x
P/S ratio	21.5x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	7.29%
EBITDA Margin	19.46%
FCF margin	6.44%
Gross margin	79.33%
Gross Profit	CNY 311.1M
Gross Profit Growth	584.35%
Gross Profit Growth Q	2,936.88%
Gross Profit Growth3 Y	164.4%
Gross Profit Growth5 Y	128.09%
Net Income	CNY 3.5M
Pretax Margin	0.88%
Profit Margin	0.88%
Profit Per Employee	CNY 11,464
ROA	1
Roa5y	-9.03
ROCE	1.92
ROE	0.31
Roe5y	-19.67
ROIC	1.17

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	163.14%
Cagr3y	23.29%
Cagr5y	9.3%
Revenue Growth	194.54x
Revenue Growth Q	948.89x
Revenue Growth3 Y	62.75x
Revenue Growth5 Y	50.12x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.22
Assets	CNY 1.9B
Cash	CNY 729.7M
Current Assets	CNY 1.3B
Current Liabilities	CNY 363.8M
Debt	CNY 471.6M
Debt EBITDA	CNY 6.12
Debt Equity	CNY 0.43
Debt FCF	CNY 18.66
Equity	CNY 1.1B
Liabilities	CNY 742.2M
Long Term Assets	CNY 562.6M
Long Term Liabilities	CNY 378.4M
Net Cash	CNY 258.1M
Net Cash By Market Cap	CNY 3.06
Net Cash Growth	-29.29%
Net Debt EBITDA	CNY -3.38
Net Debt Equity	CNY -0.23
Net Debt FCF	CNY -10.21
Tangible Book Value	CNY 986.1M
Tangible Book Value Per Share	CNY 2.65
WACC	9.33

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.54
Inventory Turnover	1.31
Net Working Capital	CNY 493.2M
Quick ratio	2.49
Working Capital	CNY 924M
Working Capital Turnover	CNY 0.48

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.42%
Payout Ratio	223.76%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	162.97%
200-day SMA	19.27
3Y total return	87.43%
50-day SMA	20.09
50-day SMA vs 200-day SMA	50over200
5Y total return	55.99%
All Time High	35.53
All Time High Change	-36.65%
All Time High Date	2020-10-28
All Time Low	4.48
All Time Low Change	402.46%
All Time Low Date	2024-09-18
ATR	1.28
Beta	1.02
Beta1y	0.11
Beta2y	0.49
Ch YTD	24.71
High	23.43
High52	29.98
High52 Date	2026-01-13
High52ch	-24.92%
Low	22.35
Low52	8.3
Low52 Date	2025-05-15
Low52ch	171.21%
Ma50ch	12.06%
Price vs 200-day SMA	16.84%
RSI	60.21
RSI Monthly	61.66
RSI Weekly	57.48
Sharpe ratio	1.6x
Sortino ratio	3.02
Total Return	-0.42%
Tr YTD	24.71
Tr1m	12.27%
Tr1w	1.26%
Tr3m	-2.55%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 28.6M
Operating margin	7.29

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	211,942,789%
Net Borrowing	105,286,781
Shares Insiders	16.08%
Shares Institutions	6.77%
Shares Out	374,578,653
Shares Qo Q	-0.39%
Shares Yo Y	0.42%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 25.3M
Average Volume	20,147,306.7x
Bv Per Share	2.97
CAPEX	CNY -14.7M
Ch1m	12.27
Ch1w	1.26
Ch1y	163
Ch3m	-2.55
Ch3y	87.43
Ch5y	55.99
Ch6m	46.55
Change	-0.4%
Change From Open	-2.13
Close	22.6
Days Gap	1.77
Depreciation Amortization	47,750,431
Dollar Volume	361,001,423.8
Earnings Date	2026-08-28
EBIT	CNY 28.6M
EBITDA	CNY 76.3M
EPS	CNY 0.01
F Score	7
FCF	CNY 25.3M
FCF EV Yield	0.31x
FCF Per Share	CNY 0.07
Financing CF	79,973,825
Fiscal Year End	December
Founded	2,002
Graham Number	0.78734
Graham Upside	-96.5
Investing CF	-150,241,121
Is Primary Listing	1
Last Earnings Date	2026-03-31
Last Report Date	2026-03-31
Ma150	19.46
Ma150ch	15.69%
Ma20	20.49
Ma20ch	9.86%
Net CF	-30,409,551
Next Earnings Date	2026-08-28
Open	23
P FCF Ratio	333.6
P OCF Ratio	211
Position In Range	14.81
Ppne	417,384,450
Price Date	2026-05-08
Price EBITDA	CNY 110
Ptbv Ratio	8.55
Relative Volume	0.8x
Revenue	392,190,208x
Tr6m	46.55%
Volume	16,037,380

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does SHA/688221 pay a dividend?

Capital-return profile for this ticker.

Performance

SHA/688221 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHA/688221?

Insider, institutional, and short-interest positioning.

Institutional ownership

+6.8%

Share of float held by funds and institutions

Insider ownership

+16.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.4%

Negative means the company is buying back shares.

Technical

SHA/688221 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

60.2

Neutral momentum band

Price vs 200-day MA

+16.8%

50/200-day relationship not available

Beta (5Y)

1.02

Moves roughly with the market

Sharpe ratio

1.60

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHA/688221

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sha/688221 stock rating?

sha/688221 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sha/688221 analysis?

The full report lives at /stocks/sha/688221/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sha/688221?

The latest report frames sha/688221 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sha/688221 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.